Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program — Michał Mazurek (2019) | RDL Network
Changsheng Ma, Young‐Hoon Kim, Yorihiko Higashino, Е. V. Shlyakhto, Sérgio Dubner, Jonathan L. Halperin, Kenneth J. Rothman, Shihai Lu, Lionel Riou França, Miney Paquette, Christine Teutsch, Menno V. Huisman, Professor Gregory Lip
Professor Gregory Lip, Jonathan L. Halperin, Lionel Riou França, Kristina Zint, Miney Paquette, Shihai Lu, Kenneth J. Rothman, Christian D Adams S, Sérgio Dubner, Menno V. Huisman, Christine Teutsch, HC Diener
Sérgio Dubner, José Francisco Kerr Saraiva, Juan Carlos Núñez Fragoso, Gonzalo Barón‐Esquivias, Christine Teutsch, Venkatesh Kumar Gurusamy, Sabrina Marler, Menno V. Huisman, Professor Gregory Lip, Cecilia Zeballos
Menno V. Huisman, Christine Teutsch, Shihai Lu, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Changsheng Ma, Kenneth J. Rothman, Ragna Lohmann, Venkatesh Kumar Gurusamy, Dorothee B. Bartels, Professor Gregory Lip
Miney Paquette, Lionel Riou França, Christine Teutsch, Hans‐Christoph Diener, Shihai Lu, Sérgio Dubner, Chang Sheng, Kenneth J. Rothman, Kristina Zint, Jonathan L. Halperin, Brian Olshansky, Menno V. Huisman, Professor Gregory Lip, Robby Nieuwlaat
Discussion(0)
No comments yet. Be the first to comment.